BACKGROUND: Atrial fibrillation (AF) is the commonest rhythm disorder and has major impact on patients. Controversy remains about the best treatment strategy between rate and rhythm control (in addition to adequate thromboprophylaxis). Rhythm control agents are associated with clinically important adverse events. AIM: The aim of this study was to assess the risk of adverse events in patients with AF receiving rhythm control agents. DESIGN OF STUDY: This is a retrospective case control note r...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Rhythm control agents and adverse events in patients with atrial fibrillation.
If you are the owner of this record, you can report an update to it here: Report update to this record